乌比基工程用于询问乌比基-蛋白质体系统和新型治疗策略
Jason Q Tang1,2, Mary M Marchand3, Gianluca Veggiani3,4
1Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, 160 College Street, Toronto, ON M5S3E1, Canada.
Cells
|August 26, 2023
概括
工程化泛素通过向泛素-蛋白酶系统 (UPS) 和病毒酶,提供了一种新的治疗策略. 这种方法克服了癌症和病毒感染等疾病的药物开发方面的挑战.
科学领域:
- 生物化学和分子生物学
- 细胞生物学 细胞生物学
- 药物发现 药物发现 药物发现
背景情况:
- 蛋白质的循环,由无素-蛋白酶体系统 (UPS) 调节,对于细胞平衡至关重要.
- UPS失调与癌症和病毒感染等疾病有关.
- 由于功能和结构冗余,针对UPS酶具有挑战性,限制了当前的治疗方法.
研究的目的:
- 审查工程化乌比奎对UPS和非UPS蛋白质的影响.
- 探索对抗病毒酶的工程化乌比奎丁的应用.
- 评估工程化泛素在指导小分子药物开发新目标方面的潜力.
主要方法:
- 文献综述侧重于工程化无处不在的应用.
- 对工程化泛素对蛋白质降解途径的影响的分析.
- 探索工程化泛素在向病毒蛋白中的作用.
主要成果:
- 工程设计的ubiquitin在调节UPS活动方面显示出潜在的潜力.
- 工程化乌比奎丁在抑制病毒酶方面表现有前途.
- 工程化无处不在素可以为以前无法使用药物的小分子的设计提供信息.
结论:
- 工程化泛素代表了对UPS相关疾病和病毒感染的有前途的治疗途径.
- 这种方法扩大了可药物向的范围,使小分子能够在新型蛋白质表面上发展.
- 对工程化泛素的进一步研究可能会导致更有选择性和更有效的治疗方法.
相关概念视频
The Proteasome
887
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
887
Regulated Protein Degradation
7.4K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.4K
Covalently Linked Protein Regulators
6.9K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.9K
The Proteasome Structure
802
The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
The proteasome is an...
802
The Unfolded Protein Response
4.7K
The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
4.7K
Export of Misfolded Proteins out of the ER
3.7K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
3.7K


